CN110604132B - 空心核-卫星状聚多巴胺载银抗菌纳米胶囊的制备方法 - Google Patents
空心核-卫星状聚多巴胺载银抗菌纳米胶囊的制备方法 Download PDFInfo
- Publication number
- CN110604132B CN110604132B CN201910915371.5A CN201910915371A CN110604132B CN 110604132 B CN110604132 B CN 110604132B CN 201910915371 A CN201910915371 A CN 201910915371A CN 110604132 B CN110604132 B CN 110604132B
- Authority
- CN
- China
- Prior art keywords
- dopamine
- silver
- poly
- satellite
- hollow core
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229920001690 polydopamine Polymers 0.000 title claims abstract description 37
- 239000002088 nanocapsule Substances 0.000 title claims abstract description 27
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 title claims abstract description 26
- 229910052709 silver Inorganic materials 0.000 title claims abstract description 26
- 239000004332 silver Substances 0.000 title claims abstract description 26
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 22
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 60
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 claims abstract description 22
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000002105 nanoparticle Substances 0.000 claims abstract description 15
- XIOUDVJTOYVRTB-UHFFFAOYSA-N 1-(1-adamantyl)-3-aminothiourea Chemical compound C1C(C2)CC3CC2CC1(NC(=S)NN)C3 XIOUDVJTOYVRTB-UHFFFAOYSA-N 0.000 claims abstract description 14
- 238000005406 washing Methods 0.000 claims abstract description 13
- 239000013154 zeolitic imidazolate framework-8 Substances 0.000 claims abstract description 12
- MFLKDEMTKSVIBK-UHFFFAOYSA-N zinc;2-methylimidazol-3-ide Chemical compound [Zn+2].CC1=NC=C[N-]1.CC1=NC=C[N-]1 MFLKDEMTKSVIBK-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229960003638 dopamine Drugs 0.000 claims abstract description 11
- 229910001961 silver nitrate Inorganic materials 0.000 claims abstract description 11
- LXBGSDVWAMZHDD-UHFFFAOYSA-N 2-methyl-1h-imidazole Chemical compound CC1=NC=CN1 LXBGSDVWAMZHDD-UHFFFAOYSA-N 0.000 claims abstract description 6
- 238000002156 mixing Methods 0.000 claims abstract description 6
- 238000003756 stirring Methods 0.000 claims abstract description 5
- 238000001291 vacuum drying Methods 0.000 claims abstract description 5
- 238000006243 chemical reaction Methods 0.000 claims abstract description 3
- 238000010438 heat treatment Methods 0.000 claims abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 238000005119 centrifugation Methods 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 4
- 239000013078 crystal Substances 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 239000013110 organic ligand Substances 0.000 claims description 2
- 229910052723 transition metal Inorganic materials 0.000 claims description 2
- 150000003624 transition metals Chemical class 0.000 claims description 2
- 241000588724 Escherichia coli Species 0.000 description 5
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 5
- 241000191967 Staphylococcus aureus Species 0.000 description 5
- 230000003385 bacteriostatic effect Effects 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 230000009471 action Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000002114 nanocomposite Substances 0.000 description 2
- 239000002086 nanomaterial Substances 0.000 description 2
- 230000005180 public health Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- ONDPHDOFVYQSGI-UHFFFAOYSA-N zinc nitrate Chemical compound [Zn+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ONDPHDOFVYQSGI-UHFFFAOYSA-N 0.000 description 2
- YSWBFLWKAIRHEI-UHFFFAOYSA-N 4,5-dimethyl-1h-imidazole Chemical compound CC=1N=CNC=1C YSWBFLWKAIRHEI-UHFFFAOYSA-N 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 231100000584 environmental toxicity Toxicity 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 150000004687 hexahydrates Chemical class 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000012621 metal-organic framework Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- GFNHODBBCUPTMB-UHFFFAOYSA-N silver;methanol;nitrate Chemical compound [Ag+].OC.[O-][N+]([O-])=O GFNHODBBCUPTMB-UHFFFAOYSA-N 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/08—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing solids as carriers or diluents
- A01N25/10—Macromolecular compounds
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A01N59/16—Heavy metals; Compounds thereof
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Environmental Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Plant Pathology (AREA)
- Agronomy & Crop Science (AREA)
- Dispersion Chemistry (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明的空心核‑卫星状聚多巴胺载银抗菌纳米胶囊的制备方法,属于纳米粒子制备技术领域。将2‑甲基咪唑和六水合硝酸锌的甲醇溶液混合,在室温下搅拌反应12小时,离心、洗涤、再分散,得到ZIF‑8纳米颗粒;再与多巴胺的甲醇溶液混合,加热到60℃反应1~7小时,离心、洗涤、再分散,获得空心聚多巴胺纳米颗粒;加入硝酸银的甲醇溶液,室温反应1小时,离心、洗涤、真空干燥,得到空心核‑卫星状聚多巴胺载银抗菌纳米胶囊。本发明制备条件温和,环境友好,操作简便,制备的聚多巴胺载银空心纳米胶囊具有很好的抗菌效果。
Description
技术领域:
本发明属于纳米粒子制备技术领域,具体涉及制备“空心核-卫星”状聚多巴胺载银抗菌纳米胶囊,并研究其在抗菌领域的应用。
技术背景:
近年来,人类的健康受到公共卫生风险的严重威胁,迫切需要制药和医学研究人员开发新的抗菌剂以应对公共卫生保健中不断增加的卫生要求。银纳米颗粒作为最有效的抗菌剂之一,具有强大的杀菌活性和广泛的抑制性杀菌,以及对人类和其他动物相对较低的毒性。然而它在实际应用中经常受到聚集的影响,将导致它们的抗菌活性减少甚至完全丧失。为了解决这个问题,科研人员已经花费大量努力将银纳米颗粒固定到各种基质上,以增强它们的稳定性和抗菌活性。迄今为止,许多材料被报道作为支持银纳米颗粒的基质。尽管它们可以保持银纳米颗粒的稳定性和抗菌活性,但合成过程复杂并伴随其他试剂的加入,如稳定剂、还原剂等,会导致环境毒性或生物危害。因此,迫切需要研究一种简单直接且环境友好的合成具有良好的生物相容性和优异的抗菌活性的银基纳米复合材料。
发明内容:
本发明要解决的技术问题是克服背景技术存在的问题,提供一种制备工艺简单高效,生物相容性好,抗菌活性高的银基纳米复合材料的制备方法。
本发明的技术方案如下:
一种空心核-卫星状聚多巴胺载银抗菌纳米胶囊的制备方法,有以下步骤:
(1)将摩尔比为2:1的2-甲基咪唑的甲醇溶液和六水合硝酸锌的甲醇溶液混合,在室温下搅拌反应12小时,离心、洗涤、再分散,得到ZIF-8纳米颗粒;所述的ZIF-8纳米颗粒是一种由过渡金属与有机配体相互结合而成的具有立体网络结构的晶体材料;
(2)将多巴胺的甲醇溶液与步骤(1)配制的ZIF-8纳米颗粒混合,加热到60℃反应1~7小时,离心、洗涤、再分散,获得空心聚多巴胺(PDA)纳米颗粒;所述的多巴胺的甲醇溶液的浓度为10~50mmol/L;按摩尔计,多巴胺的用量与步骤(1)中的六水合硝酸锌的用量比例为0.08~0.4:1;
(3)向步骤(2)制备的空心聚多巴胺纳米颗粒中加入硝酸银的甲醇溶液,室温反应1小时,离心、洗涤、真空干燥,得到空心核-卫星状聚多巴胺载银抗菌纳米胶囊;按摩尔计,硝酸银的用量与步骤(1)中六水合硝酸锌用量比例为0.07~0.28:1。
在步骤(1)中,所述的2-甲基咪唑溶液浓度优选40mmol/L;所述的六水合硝酸锌溶液浓度优选20mmol/L;所述的搅拌速度优选500转/分钟;
在步骤(2)中,按摩尔计,多巴胺的用量与步骤(1)中的六水合硝酸锌的用量比例优选为0.26:1。
在步骤(3)中,所述的硝酸银的浓度优选8mg/mL;按摩尔计,硝酸银的用量与步骤(1)中六水合硝酸锌用量比例优选0.07:1。
步骤(1)、(2)、(3)中所述的离心、洗涤条件具体是在6000~9000转/分钟条件下离心5~15分钟、无水乙醇洗涤3~5次;步骤(3)中所述的真空干燥具体是指30℃~40℃真空干燥12~24小时。
有益效果:
1、本发明制备了“空心核-卫星”状聚多巴胺载银纳米胶囊,制备条件温和,环境友好,操作简便。
2、本发明采用的自刻蚀模板ZIF-8是一种金属有机框架,随着聚多巴胺壳逐渐形成,ZIF-8中的Zn2+与聚多巴胺发生配位作用,ZIF-8模板不断被刻蚀,最终消失,形成空心聚多巴胺纳米胶囊。
3、本发明采用聚多巴胺原位还原硝酸银,在空心聚多巴胺核上生长了一层单分散性好、稳定性高的银纳米颗粒。
4、本发明聚多巴胺载银空心纳米胶囊具有很好的抗菌效果,银粒子和Zn2+共同作用发挥抑菌功能。
附图说明:
图1为本发明实施例1制备的空心聚多巴胺纳米结构的透射电子显微镜照片。
图2为本发明实施例2制备的“空心核-卫星”状聚多巴胺载银纳米胶囊的透射电子显微镜照片
图3聚多巴胺载银纳米胶囊对金黄葡萄球菌的抑菌效果
图4聚多巴胺载银纳米胶囊对大肠杆菌的抑菌效果
具体实施方法:
以下是本发明的实施例用到的基础条件,但本发明能实施的范围并不限于这些条件,也不限于这些实施例:
环境温度30℃,1个大气压;
六水和硝酸锌,分子量297.49g/mol;
二甲基咪唑,分子量82.10g/mol;
无水甲醇,密度0.791g/mL,分子量32.04g/mol;
无水乙醇,密度0.789g/mL,分子量46.07g/mol
多巴胺(HDA),分子量189.64g/mol;
硝酸银,分子量169.87g/mol。
实施例1:
将5ml的2-甲基咪唑(40mM)和5ml的六水合硝酸锌(20mM)溶液混合,在室温下500rpm反应12h。通过8000rpm离心10min收集产物,用乙醇洗涤数次,并最终分散在3.0mL甲醇中。得到ZIF-8纳米颗粒。
将上述3.0mL ZIF-8甲醇溶液加入到5.0mL甲醇中,与0.8mL多巴胺甲醇溶液(32.5mM)混合。将混合物搅拌并在60℃下回流5h,其颜色逐渐从乳白色变为黑色。通过8000rpm离心5min收集所得物,用乙醇洗涤三次,并最终分散在6.0mL甲醇中。得到的空心聚多巴胺纳米结构如图1所示。
取2mL上述分散液并加入1mL甲醇稀释,然后与50μL硝酸银甲醇溶液(8mg/mL)混合,在室温下搅拌1h。将产物离心并用乙醇冲洗数次。随后,将聚多巴胺载银空心纳米胶囊冷冻干燥,得到聚多巴胺载银空心纳米胶囊,如图2所示。
实施例2:
采用摇瓶法评价实施案例1中制备的聚多巴胺载银空心纳米胶囊对金葡萄球菌(革兰氏阳性菌)和大肠杆菌(革兰氏阴性菌)的抑菌效果,测试结果如图3、图4所示。
将金葡萄球菌和大肠杆菌在LB(Luria-Berrani)培养液中37℃培养12h。取一定量10mg/mL聚多巴胺载银空心纳米胶囊分散在5mL培养液中,分别加入50μL浓度为107CFU/mL的金色葡萄球菌和大肠杆菌悬浮液。在37℃中孵育,通过监测600nm处的光密度,来测量细菌的生长速度。图3是金色葡萄球菌的抑菌效果,图4是大肠杆菌的抑菌效果;从图中明显看出,当聚多巴胺载银空心纳米胶囊的终浓度为16μg/mL时,可完全抑制两种细菌的生长。
Claims (5)
1.一种空心核-卫星状聚多巴胺载银抗菌纳米胶囊的制备方法,有以下步骤:
(1)将摩尔比为2:1的2-甲基咪唑的甲醇溶液和六水合硝酸锌的甲醇溶液混合,在室温下搅拌反应12小时,离心、洗涤、再分散,得到ZIF-8纳米颗粒;所述的ZIF-8纳米颗粒是一种由过渡金属与有机配体相互结合而成的具有立体网络结构的晶体材料;
(2)将多巴胺的甲醇溶液与步骤(1)配制的ZIF-8纳米颗粒混合,加热到60℃反应1~7小时,离心、洗涤、再分散,获得空心聚多巴胺纳米颗粒;所述的多巴胺的甲醇溶液的浓度为10~50mmol/L;按摩尔计,多巴胺的用量与步骤(1)中的六水合硝酸锌的用量比例为0.08~0.4:1;
(3)向步骤(2)制备的空心聚多巴胺纳米颗粒中加入硝酸银的甲醇溶液,室温反应1小时,离心、洗涤、真空干燥,得到空心核-卫星状聚多巴胺载银抗菌纳米胶囊;按摩尔计,硝酸银的用量与步骤(1)中六水合硝酸锌用量比例为0.07~0.28:1。
2.根据权利要求1所述的一种空心核-卫星状聚多巴胺载银抗菌纳米胶囊的制备方法,其特征在于,在步骤(1)中,所述的2-甲基咪唑溶液浓度为40mmol/L;所述的六水合硝酸锌溶液浓度为20mmol/L;所述的搅拌,速度为500转/分钟。
3.根据权利要求1所述的一种空心核-卫星状聚多巴胺载银抗菌纳米胶囊的制备方法,其特征在于,在步骤(2)中,按摩尔计,多巴胺的用量与步骤(1)中的六水合硝酸锌的用量比例为0.26:1。
4.根据权利要求1所述的一种空心核-卫星状聚多巴胺载银抗菌纳米胶囊的制备方法,其特征在于,在步骤(3)中,所述的硝酸银的浓度为8mg/mL;按摩尔计,硝酸银的用量与步骤(1)中六水合硝酸锌用量比例为0.07:1。
5.根据权利要求1~4任一所述的一种空心核-卫星状聚多巴胺载银抗菌纳米胶囊的制备方法,其特征在于,步骤(1)、(2)、(3)中所述的离心、洗涤条件是在6000~9000转/分钟条件下离心5~15分钟、无水乙醇洗涤3~5次;步骤(3)中所述的真空干燥是指30~40℃真空干燥12~24小时。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910915371.5A CN110604132B (zh) | 2019-09-26 | 2019-09-26 | 空心核-卫星状聚多巴胺载银抗菌纳米胶囊的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910915371.5A CN110604132B (zh) | 2019-09-26 | 2019-09-26 | 空心核-卫星状聚多巴胺载银抗菌纳米胶囊的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110604132A CN110604132A (zh) | 2019-12-24 |
CN110604132B true CN110604132B (zh) | 2021-10-08 |
Family
ID=68893126
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910915371.5A Expired - Fee Related CN110604132B (zh) | 2019-09-26 | 2019-09-26 | 空心核-卫星状聚多巴胺载银抗菌纳米胶囊的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110604132B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115287123A (zh) * | 2022-08-03 | 2022-11-04 | 上海应用技术大学 | 一种稳固中空金属-酚醛网络香精微胶囊及其制备方法 |
CN115918651B (zh) * | 2022-12-29 | 2024-10-01 | 西安交通大学 | Zif-8/正辛基三乙氧基硅烷抗菌喷雾及其制备方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105879841A (zh) * | 2016-05-31 | 2016-08-24 | 河南师范大学 | 一种用于选择性吸附废水中铅离子的SiO2@PDA@ZIF-8复合吸附剂及其制备方法 |
WO2017079976A1 (en) * | 2015-11-13 | 2017-05-18 | Robert Bosch Gmbh | Sulfur-carbon composite comprising a highly graphitic carbon material for lithium-sulfur batteries and process for preparing the same |
CN109311662A (zh) * | 2016-03-24 | 2019-02-05 | 南洋理工大学 | 核壳等离子体纳米间隙的纳米结构材料 |
CN109569521A (zh) * | 2018-12-10 | 2019-04-05 | 南昌航空大学 | 一种罗丹宁功能化MOFs吸附剂及其制备方法和应用 |
CN109673636A (zh) * | 2019-01-15 | 2019-04-26 | 南京工业大学 | 一种基于植物多酚制备核壳结构纳米银抗菌材料的方法 |
CN109705575A (zh) * | 2019-03-01 | 2019-05-03 | 兰州交通大学 | 铁酸钴/聚多巴胺/银复合纳米立方体抗菌剂的制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109892326A (zh) * | 2019-03-25 | 2019-06-18 | 合肥工业大学 | 一种载银含锌复合纳米球抗菌剂及其制备方法 |
-
2019
- 2019-09-26 CN CN201910915371.5A patent/CN110604132B/zh not_active Expired - Fee Related
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017079976A1 (en) * | 2015-11-13 | 2017-05-18 | Robert Bosch Gmbh | Sulfur-carbon composite comprising a highly graphitic carbon material for lithium-sulfur batteries and process for preparing the same |
CN109311662A (zh) * | 2016-03-24 | 2019-02-05 | 南洋理工大学 | 核壳等离子体纳米间隙的纳米结构材料 |
CN105879841A (zh) * | 2016-05-31 | 2016-08-24 | 河南师范大学 | 一种用于选择性吸附废水中铅离子的SiO2@PDA@ZIF-8复合吸附剂及其制备方法 |
CN109569521A (zh) * | 2018-12-10 | 2019-04-05 | 南昌航空大学 | 一种罗丹宁功能化MOFs吸附剂及其制备方法和应用 |
CN109673636A (zh) * | 2019-01-15 | 2019-04-26 | 南京工业大学 | 一种基于植物多酚制备核壳结构纳米银抗菌材料的方法 |
CN109705575A (zh) * | 2019-03-01 | 2019-05-03 | 兰州交通大学 | 铁酸钴/聚多巴胺/银复合纳米立方体抗菌剂的制备方法 |
Non-Patent Citations (1)
Title |
---|
"Facile synthesis of Ag@ZIF-8 core-shell heterostructure nanowires for improved antibacterial activities";Yu-Feng Guo et al.;《Applied surface science》;20171113;第149-155页 * |
Also Published As
Publication number | Publication date |
---|---|
CN110604132A (zh) | 2019-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Jayaramudu et al. | Chitosan-pluronic based Cu nanocomposite hydrogels for prototype antimicrobial applications | |
CN110604132B (zh) | 空心核-卫星状聚多巴胺载银抗菌纳米胶囊的制备方法 | |
CN101731272B (zh) | 一种抗菌纳米银溶胶的制备方法 | |
Huang et al. | Optical properties of biomass-derived nanomaterials for sensing, catalytic, biomedical and environmental applications | |
Spagnol et al. | Cellulose nanowhiskers decorated with silver nanoparticles as an additive to antibacterial polymers membranes fabricated by electrospinning | |
Drogat et al. | Antimicrobial silver nanoparticles generated on cellulose nanocrystals | |
Sacourbaravi et al. | Fabrication of Ag NPs/Zn-MOF nanocomposites and their application as antibacterial agents | |
CN107142538A (zh) | 一种金属有机框架复合抗菌纤维素纤维填料的制备方法 | |
Nabipour et al. | Synthesis, characterisation and sustained release properties of layered zinc hydroxide intercalated with amoxicillin trihydrate | |
Ahmad et al. | Significant improvement in antibacterial property of ZIF-8 decorated graphene oxide by post-synthetic modification process | |
CN100525965C (zh) | 铜镍双金属纳米颗粒的制备方法 | |
CN105379758B (zh) | 载银伊蒙黏土/壳聚糖季铵盐杂化抗菌剂的制备方法 | |
CN108889303B (zh) | 二氧化碳制甲醇的负载型高分散铜基催化剂及制法和应用 | |
Li et al. | Preparation and application of silver/chitosan-sepiolite materials with antimicrobial activities and low cytotoxicity | |
CN109892326A (zh) | 一种载银含锌复合纳米球抗菌剂及其制备方法 | |
CN100512650C (zh) | 一种抗菌防霉剂的制备方法 | |
CN111410809A (zh) | 一种基于有机金属骨架的持续性抗菌聚乙烯醇薄膜及其制备方法 | |
Qin et al. | Preparation of SiO2@ Ag composite nanoparticles and their antimicrobial activity | |
Chen et al. | Ag nanoparticles decorated hybrid microspheres for superior antibacterial properties | |
KR102424759B1 (ko) | 금속 산화물 반도체 나노물질의 조성물 | |
CN105596366B (zh) | 具有三明治夹层结构Ag/CNTs/GO复合物的制备 | |
CN113367157A (zh) | 一种花状银/木质素复合抗菌颗粒的制备方法 | |
CN110153440B (zh) | 一种日本曲霉发酵液绿色制备纳米银的方法及应用 | |
Nguyen et al. | The chitosan/ZnO bio-nanocomposites with selective antibacterial efficiency | |
CN105638729B (zh) | 一种中空结构球状银/氯化银复合材料及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20211008 |